Enterprise Bank & Trust Co Acquires 506 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Enterprise Bank & Trust Co boosted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 7.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,402 shares of the medical research company’s stock after purchasing an additional 506 shares during the quarter. Enterprise Bank & Trust Co’s holdings in Thermo Fisher Scientific were worth $2,156,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of TMO. Ellevest Inc. increased its stake in Thermo Fisher Scientific by 137.5% in the second quarter. Ellevest Inc. now owns 95 shares of the medical research company’s stock worth $28,000 after purchasing an additional 55 shares during the period. Massey Quick Simon & CO. LLC purchased a new stake in Thermo Fisher Scientific in the second quarter worth $30,000. Redhawk Wealth Advisors Inc. purchased a new position in shares of Thermo Fisher Scientific during the second quarter valued at $31,000. Prestige Wealth Management Group LLC purchased a new position in shares of Thermo Fisher Scientific during the second quarter valued at $32,000. Finally, Lenox Wealth Advisors LLC increased its stake in shares of Thermo Fisher Scientific by 55.2% during the third quarter. Lenox Wealth Advisors LLC now owns 135 shares of the medical research company’s stock valued at $39,000 after buying an additional 48 shares during the period. Institutional investors and hedge funds own 88.18% of the company’s stock.

NYSE TMO traded down $0.25 during trading on Monday, hitting $292.05. The company’s stock had a trading volume of 49,361 shares, compared to its average volume of 1,560,833. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.49 and a quick ratio of 1.07. The company has a market cap of $113.30 billion, a PE ratio of 26.26, a P/E/G ratio of 1.85 and a beta of 1.13. The business’s 50 day simple moving average is $286.01 and its 200-day simple moving average is $280.15. Thermo Fisher Scientific Inc. has a fifty-two week low of $208.34 and a fifty-two week high of $305.45.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, July 24th. The medical research company reported $3.04 earnings per share for the quarter, topping the consensus estimate of $3.01 by $0.03. Thermo Fisher Scientific had a return on equity of 17.11% and a net margin of 14.24%. The business had revenue of $6.32 billion during the quarter, compared to the consensus estimate of $6.31 billion. During the same quarter last year, the company earned $2.75 earnings per share. The company’s quarterly revenue was up 3.9% on a year-over-year basis. Analysts expect that Thermo Fisher Scientific Inc. will post 12.25 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, September 17th will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.26%. The ex-dividend date of this dividend is Monday, September 16th. Thermo Fisher Scientific’s dividend payout ratio is currently 6.83%.

Several equities analysts have recently commented on TMO shares. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $299.00 price target on the stock in a research note on Wednesday, June 12th. Barclays set a $330.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Monday, July 15th. Credit Suisse Group reissued a “buy” rating and issued a $310.00 target price on shares of Thermo Fisher Scientific in a research report on Wednesday, July 31st. Needham & Company LLC raised their price target on Thermo Fisher Scientific from $315.00 to $321.00 and gave the stock a “buy” rating in a research report on Thursday, July 25th. Finally, ValuEngine downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $303.17.

In related news, CEO Marc N. Casper sold 2,271 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $298.00, for a total transaction of $676,758.00. Following the completion of the transaction, the chief executive officer now directly owns 283,502 shares in the company, valued at $84,483,596. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $284.83, for a total value of $14,241,500.00. Following the transaction, the chief executive officer now owns 342,193 shares of the company’s stock, valued at $97,466,832.19. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 54,104 shares of company stock valued at $15,418,539. 0.45% of the stock is owned by company insiders.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Recommended Story: Asset Allocation, Balancing Your Investments

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.